fashion -WSS

fashion

author：focus 2025-09-30 00:38:24 - browse：49

Sanofi, the Paris-based drug giant, announced Friday that it would spin out its $5 billion consumer health division, which is exploring over-the-counter moves for the erectile dysfunction drug Cialis and the flu treatment Tamiflu.

Investors reacted swiftly, bidding Sanofi’s American depository receipts on the New York Stock Exchange down nearly 18% to less than $44 in morning trading. Jared Holz, an analyst at Mizuho, warned investors that the drop “would be the largest negative single-day stock move across Global Pharma in more than ten years.”

It would be tempting to take the stock move as evidence that investors have finally tired of watching drug companies treat consumer product divisions like baseball trading cards, buying them at a high price only to sell them again a decade later. But the move probably has little to do with the current passion for pharma spinouts or with Sanofi following in the footsteps of GSK, Novartis, and Pfizer in shedding a division. Or even, for that matter, Sanofi, which shed its pharmaceutical ingredients business, EuroAPI, which is now trading at a third of its initial public offering price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Why health records don't always know when patients are dead

WSS

Eli Lilly expects to double planned employment in Boston center

Studies point to risks of excluding people with obesity from drug trials

SNAP should offer more nutrition education

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Medicare drug price negotiation hasn't dried up venture capital

Albert Bourla of Pfizer: worst biopharma CEO of 2023

explore

fashion

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

2023 STAT Wunderkinds: get to know the winners

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

What STAT readers think about the FDA and patient advocacy

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Editas, Vertex strike deal on CRISPR

Anesthesiologist group: stop taking Ozempic before surgery

Why health records don't always know when patients are dead

Supreme Court strikes down use of affirmative action

What STAT readers think about the FDA and patient advocacy

focus

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

Hospital price transparency does save money, advocate argues

How climate

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

First Opinion Podcast: Long Covid needs a new approach

UnitedHealth’s board chair also owns a personal investment firm

hotspot

entertainment

explore

hotspot